Related Experiment Video

Updated: Aug 24, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Yushida: an IoT-based smart injection system for long-term management of chronic diseases

Lifang Lei1, Renjun Ma2, Fang Lin1

  • 1Xiamen Amoytop Biotech Co., Ltd, Xiamen, Fujian, China.

Frontiers in Digital Health
|August 22, 2026
PubMed

Insights

Yushida is a new smart injection system for chronic diseases, improving dosing accuracy and adherence. This Internet of Things device offers voice guidance and data logging for better long-term treatment management.

Area of Science:

  • Biomedical Engineering
  • Digital Health
  • Pharmacology

Background:

  • Accurate dosing and adherence are crucial for chronic disease management via subcutaneous injections.
  • Pediatric patients require specialized injection devices for safety, precision, and adherence monitoring.
  • Current injection devices have limitations in tracking medication, assessing adherence, and managing long-term treatments.

Purpose of the Study:

  • To introduce Yushida, an IoT-based smart injection system.
  • To examine the device architecture and digital functionalities of Yushida.
  • To compare Yushida with existing smart injection systems and discuss its clinical utility and implementation challenges.

Main Methods:

  • Systematic examination of Yushida's device architecture and digital features.
  • Comparison with current representative smart injection systems.
  • Discussion of potential clinical utility and implementation challenges.

Main Results:

  • Yushida integrates a concealed-needle cartridge, sensing system, Bluetooth, voice guidance, and automatic data logging.
  • The device aims to address limitations in medication tracking and adherence assessment.
  • Quantitative clinical impact data for Yushida is currently limited, with ongoing studies.

Conclusions:

  • Yushida represents a novel digitalized injection therapy approach.
  • Further clinical and real-world studies are needed to fully evaluate its utility.
  • The development of smart injection systems is crucial for advancing long-term disease management.

Keywords:
adherence monitoringchronic disease managementdigital healthinternet of thingssmart injection systemtreatment adherence

More Related Videos

Microinjectrode System for Combined Drug Infusion and Electrophysiology08:30

Microinjectrode System for Combined Drug Infusion and Electrophysiology

Published on: November 13, 2019

Lumbar Intrathecal Injection of SOD1-ASOs for Precise CNS Targeting and Predictive Efficacy in Human SOD1-G93A ALS Mice04:41

Lumbar Intrathecal Injection of SOD1-ASOs for Precise CNS Targeting and Predictive Efficacy in Human SOD1-G93A ALS Mice

Published on: February 24, 2026

Related Concept Videos

Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices01:28

Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices

Parenteral drug delivery systems play a crucial role in modern therapeutics by enabling the direct administration of drugs into the systemic circulation, bypassing the gastrointestinal tract. These systems are particularly valuable for poorly absorbed oral medications that are unstable in the digestive environment or require rapid onset or sustained therapeutic levels. Delivery is achieved through intravenous, intramuscular, or subcutaneous routes, each selected based on the drug's properties...
Drug Accumulation During Multiple Dosing: Repetitive IV Injections01:21

Drug Accumulation During Multiple Dosing: Repetitive IV Injections

Calculating drug dosage and accumulation in multiple-dose regimens is crucial for achieving therapeutic efficacy while avoiding toxicity. This involves determining the plasma drug concentrations over time to optimize dosing schedules. The principle of superposition is fundamental in this process, allowing for the prediction of drug concentration in plasma following multiple doses based on single-dose data.The principle of superposition asserts that the plasma concentration-time curves from...
Modified-Release Drug Delivery Systems: Rate-Programmed I01:22

Modified-Release Drug Delivery Systems: Rate-Programmed I

Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
Integrated Healthcare System01:20

Integrated Healthcare System

An integrated healthcare system (IHS) is a set of organizations that provides for or arranges to provide coordinated and continuous service to a defined population. The IHS takes responsibility for that particular population's health status and outcome, both clinically and fiscally. An integrated healthcare system is a well-organized, well-coordinated, and collaborative network. The integrated delivery system is a network that connects different healthcare providers to deliver organized,...
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
Intrauterine Drug Delivery Systems01:21

Intrauterine Drug Delivery Systems

Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...